UB Paderborn / Katalog / Suche / in CDI

HER2 Status in Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma for Entry to the TRIO-013/LOGiC Trial of Lapatinib

Molecular cancer therapeutics, 2017-01, Vol.16 (1), p.228-238

2017

Link zum Volltext

Verfügbarkeit prüfen

Dramatic elevation in urinary amino terminal titin fragment excretion quantified by immunoassay in duchenne muscular dystrophy patients and in dystrophin deficient rodents

Neuromuscular disorders : NMD, 2017-07, Vol.27 (7), p.635-645

2017

Link zum Volltext

Verfügbarkeit prüfen

Efficacy, safety, pharmacokinetics and biomarker findings in patients with HER2-positive advanced or metastatic breast cancer treated with lapatinib in combination with capecitabine: results from 51 Japanese patients treated in a clinical study

Breast cancer (Tokyo, Japan), 2015-03, Vol.22 (2), p.192-200

2015

Link zum Volltext

Verfügbarkeit prüfen

A Phase I/II Multicenter Study of Single-Agent Foretinib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma

Clinical cancer research, 2017-05, Vol.23 (10), p.2405-2413

2017

Link zum Volltext

Verfügbarkeit prüfen

Kinetic profile of a heterocyclic HCV replicon RNA synthesis inhibitor

Biochemical and biophysical research communications, 2003-11, Vol.311 (3), p.672-677

2003

Link zum Volltext

Verfügbarkeit prüfen

Modification of the Fc Region of a Primatized IgG Antibody to Human CD4 Retains Its Ability to Modulate CD4 Receptors but Does Not Deplete CD4+ T Cells in Chimpanzees

Clinical immunology (Orlando, Fla.), 2001-02, Vol.98 (2), p.164-174

2001

Link zum Volltext

Verfügbarkeit prüfen

Correlation of PDL1 tumor expression and outcomes in renal cell carcinoma (RCC) patients (pts) treated with pazopanib (paz)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.3021-3021

2013

Link zum Volltext

Verfügbarkeit prüfen

Osteopontin (OPN), TIMP-1, and interleukin (IL)-6 as prognostic (prog) for overall survival (OS) and independent from clinical criteria in patients (pts) with metastatic renal cell carcinoma (mRCC)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.4582-4582

2014

Link zum Volltext

Verfügbarkeit prüfen

Design of experiments with unknown parameters in variance

Applied stochastic models in business and industry, 2002-07, Vol.18 (3), p.207-218

2002

Link zum Volltext

Verfügbarkeit prüfen

Correlation of PDL1 tumor expression and treatment outcomes in patients with renal cell carcinoma (RCC) receiving tyrosine kinase inhibitors: COMPARZ study analysis

Journal of clinical oncology, 2014-02, Vol.32 (4_suppl), p.416-416

2014

Link zum Volltext

Verfügbarkeit prüfen

Correlation of chromosome (Chr) 14 loss and 5q gain with outcomes of pazopanib treatment in patients (pts) with metastatic clear cell renal cell carcinoma (mRCC)

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.4605-4605

2012

Link zum Volltext

Verfügbarkeit prüfen

Concordance study of HER2 fluorescence in situ hybridization (FISH) assays in upper gastrointestinal (UGI) adenocarcinomas

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.4072-4072

2014

Link zum Volltext

Verfügbarkeit prüfen

Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994

Archives of internal medicine (1960), 2000-06, Vol.160 (11), p.1683

2000

Link zum Volltext

Verfügbarkeit prüfen

Reassessment of a proposed molecular classification system for clear cell renal cell cancer (ccRCC): Results from a randomized phase II trial of pazopanib

Journal of clinical oncology, 2012-02, Vol.30 (5_suppl), p.404-404

2012

Link zum Volltext

Verfügbarkeit prüfen

Association between circulating hepatocyte growth factor (HGF) and clinical response across five studies with the BRAF inhibitor dabrafenib or MEK inhibitor trametinib

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e20019-e20019

2014

Link zum Volltext

Verfügbarkeit prüfen

Circulating cytokines and angiogenic factors (CAF) as markers of clinical response in the study of trametinib (T) plus gemcitabine (G) versus placebo (P) plus gemcitabine for patients (pts) with untreated metastatic adenocarcinoma of the pancreas (MEK113487)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.4042-4042

2013

Link zum Volltext

Verfügbarkeit prüfen

Assessment of a cell-line-derived HIF1α gene signature in tumor tissue from a metastatic renal cell carcinoma (RCC) trial of pazopanib

Journal of clinical oncology, 2012-02, Vol.30 (5_suppl), p.408-408

2012

Link zum Volltext

Verfügbarkeit prüfen

Cytomegalovirus infection in pregnancy

Journal of obstetrics and gynaecology Canada, 2010-04, Vol.32 (4), p.355-362

2010

Link zum Volltext

Verfügbarkeit prüfen

Genomic alterations in paired pretreatment (pre) and progression (prog) tumor samples from ovarian cancer patients (pts) treated with pazopanib (pazo) or placebo (plb)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.5501-5501

2014

Link zum Volltext

Verfügbarkeit prüfen

Tumor-specific circulating cell-free DNA (cfDNA) BRAF mutations (muts) to predict clinical outcome in patients (pts) treated with the BRAF inhibitor dabrafenib (GSK2118436)

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.8518-8518

2012

Link zum Volltext

Verfügbarkeit prüfen

Abstract B210: Shed MET (sMET), VEGFA, and sVEGFR2 are markers of foretinib treatment in metastatic gastric cancer patients

Molecular cancer therapeutics, 2009-12, Vol.8 (12_Supplement), p.B210-B210

2009

Link zum Volltext

Verfügbarkeit prüfen

Abstract SY23-03: Oncogenic signal transduction via the hepatocyte growth factor/Met receptor kinase pathway

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.SY23-03-SY23-03

2010

Link zum Volltext

Verfügbarkeit prüfen

Estimation of confidence intervals for area under the curve from destructively obtained pharmacokinetic data

Journal of pharmacokinetics and biopharmaceutics, 1998-02, Vol.26 (1), p.87-102

1998

Link zum Volltext

Verfügbarkeit prüfen

Concomitant cortical expression of TNF-alpha and IL-1 beta mRNAs follows early response gene expression in transient focal ischemia

Molecular and chemical neuropathology, 1994-10, Vol.23 (2-3), p.103-114

1994

Link zum Volltext

Verfügbarkeit prüfen

Neuroprotective effects of SKF 10,047 in cultured rat cerebellar neurons and in gerbil global brain ischemia

Stroke (1970), 1992-03, Vol.23 (3), p.414-419

1992

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

HER2 Status in Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma for Entry to the TRIO-013/LOGiC Trial of Lapatinib

Dramatic elevation in urinary amino terminal titin fragment excretion quantified by immunoassay in duchenne muscular dystrophy patients and in dystrophin deficient rodents

Efficacy, safety, pharmacokinetics and biomarker findings in patients with HER2-positive advanced or metastatic breast cancer treated with lapatinib in combination with capecitabine: results from 51 Japanese patients treated in a clinical study

A Phase I/II Multicenter Study of Single-Agent Foretinib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma

Kinetic profile of a heterocyclic HCV replicon RNA synthesis inhibitor

Modification of the Fc Region of a Primatized IgG Antibody to Human CD4 Retains Its Ability to Modulate CD4 Receptors but Does Not Deplete CD4+ T Cells in Chimpanzees

Correlation of PDL1 tumor expression and outcomes in renal cell carcinoma (RCC) patients (pts) treated with pazopanib (paz)

Osteopontin (OPN), TIMP-1, and interleukin (IL)-6 as prognostic (prog) for overall survival (OS) and independent from clinical criteria in patients (pts) with metastatic renal cell carcinoma (mRCC)

Design of experiments with unknown parameters in variance

Correlation of PDL1 tumor expression and treatment outcomes in patients with renal cell carcinoma (RCC) receiving tyrosine kinase inhibitors: COMPARZ study analysis

Correlation of chromosome (Chr) 14 loss and 5q gain with outcomes of pazopanib treatment in patients (pts) with metastatic clear cell renal cell carcinoma (mRCC)

Concordance study of HER2 fluorescence in situ hybridization (FISH) assays in upper gastrointestinal (UGI) adenocarcinomas

Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994

Reassessment of a proposed molecular classification system for clear cell renal cell cancer (ccRCC): Results from a randomized phase II trial of pazopanib

Association between circulating hepatocyte growth factor (HGF) and clinical response across five studies with the BRAF inhibitor dabrafenib or MEK inhibitor trametinib

Circulating cytokines and angiogenic factors (CAF) as markers of clinical response in the study of trametinib (T) plus gemcitabine (G) versus placebo (P) plus gemcitabine for patients (pts) with untreated metastatic adenocarcinoma of the pancreas (MEK113487)

Assessment of a cell-line-derived HIF1α gene signature in tumor tissue from a metastatic renal cell carcinoma (RCC) trial of pazopanib

Cytomegalovirus infection in pregnancy

Genomic alterations in paired pretreatment (pre) and progression (prog) tumor samples from ovarian cancer patients (pts) treated with pazopanib (pazo) or placebo (plb)

Tumor-specific circulating cell-free DNA (cfDNA) BRAF mutations (muts) to predict clinical outcome in patients (pts) treated with the BRAF inhibitor dabrafenib (GSK2118436)

Abstract B210: Shed MET (sMET), VEGFA, and sVEGFR2 are markers of foretinib treatment in metastatic gastric cancer patients

Abstract SY23-03: Oncogenic signal transduction via the hepatocyte growth factor/Met receptor kinase pathway

Estimation of confidence intervals for area under the curve from destructively obtained pharmacokinetic data

Concomitant cortical expression of TNF-alpha and IL-1 beta mRNAs follows early response gene expression in transient focal ischemia

Neuroprotective effects of SKF 10,047 in cultured rat cerebellar neurons and in gerbil global brain ischemia

Suchergebnisse filtern